Dyloject, a Novel Injectable Diclofenac Formulation, Offers Greater Safety and Efficacy Than Voltarol for Postoperative Dental Pain

IV bolus HPβCD diclofenac sodium produced analgesia more quickly than, and with equal duration as, the 30-minute PG-BA diclofenac sodium infusion. Pooled data on thrombophlebitis from the present investigation and our prior studies of the novel formulation indicate this adverse effect is less frequent and less severe with HPβCD diclofenac sodium than with PG-BA diclofenac sodium.